Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION
Document Type and Number:
Japanese Patent JP2018168184
Kind Code:
A
Abstract:
To provide compounds and compositions that reduce mRNA and protein expression of ApoCIII for preventing, delaying or ameliorating a cardiovascular disease, disorder, condition or symptom thereof or onset of a cardiovascular disease, disorder, condition or symptom thereof.SOLUTION: The pharmaceutical composition comprises a compound targeting ApoCIII, a) for treating, preventing, delaying or improving pancreatitis; b) for raising the HDL level and/or improving the ratio of TG to HDL thereby preventing, delaying or ameliorating a cardiovascular disease, disorder, condition or symptom thereof or onset of a cardiovascular disease, disorder, condition or symptom thereof, or reducing the risk thereof; c) for increasing fat clearance, chylomicron triglyceride clearance and/or postprandial triglyceride clearance. In an embodiment of the pharmaceutical composition, the compound is a modified oligonucleotide.SELECTED DRAWING: None

Inventors:
ADAM MULLICK
ROSANNE M CROOKE
MARK J GRAHAM
KENNETH W DOBIE
THOMAS A BELL
RICHARD LEE
Application Number:
JP2018128233A
Publication Date:
November 01, 2018
Filing Date:
July 05, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
IONIS PHARMACEUTICALS INC
International Classes:
A61K31/7088; A61P1/18; A61P3/06; A61P9/00; A61P43/00; C12N15/113
Attorney, Agent or Firm:
Shinjiro Ono
Osamu Yamamoto
Toru Miyamae
Motoharu Nakanishi
Hiroko Ejiri